{"title": "The regulation of HIV-1 transcription: molecular targets for chemotherapeutic intervention", "pubDate": "2006", "PMCID": "PMC7168390", "DOI": "10.1002/med.20081", "PMID": "16838299", "abstract": "The regulation of transcription of the human immunodeficiency virus (HIV) is a complex event that requires the cooperative action of both viral and cellular components. In latently infected resting CD4(+) T cells HIV-1 transcription seems to be repressed by deacetylation events mediated by histone deacetylases (HDACs). Upon reactivation of HIV-1 from latency, HDACs are displaced in response to the recruitment of histone acetyltransferases (HATs) by NF-kappaB or the viral transcriptional activator Tat and result in multiple acetylation events. Following chromatin remodeling of the viral promoter region, transcription is initiated and leads to the formation of the TAR element. The complex of Tat with p-TEFb then binds the loop structures of TAR RNA thereby positioning CDK9 to phosphorylate the cellular RNA polymerase II. The Tat-TAR-dependent phosphorylation of RNA polymerase II plays an important role in transcriptional elongation as well as in other post-transcriptional events. As such, targeting of Tat protein (and/or cellular cofactors) provide an interesting perspective for therapeutic intervention in the HIV replicative cycle and may afford lifetime control of the HIV infection.", "author": [{"author": "Miguel Stevens", "affiliation": ["Rega Institute for Medical Research, Minderbroedersstraat 10, B-3000 Leuven, Belgium."], "href": "/?term=Stevens+M&cauthor_id=16838299"}, {"author": "Erik De Clercq", "affiliation": [], "href": "/?term=De+Clercq+E&cauthor_id=16838299"}, {"author": "Jan Balzarini", "affiliation": [], "href": "/?term=Balzarini+J&cauthor_id=16838299"}], "refPMID": ["2236022", "8280476", "2398545", "3260404", "7636977", "2964084", "7657162", "1727502", "8202539", "2033658", "8662628", "9789010", "1827423", "1555239", "7707499", "10212261", "8084021", "15194764", "2657100", "2006421", "7836461", "9371597", "10888618", "11940654", "12414976", "15857981", "7745706", "8440240", "2269426", "9199312", "9223506", "8702837", "12021315", "15659847", "11846973", "3031512", "2065663", "1314883", "2112750", "10605930", "2263644", "9299585", "10521409", "15128824", "9268159", "1724477", "1482376", "7683414", "7542738", "1431113", "8052854", "8509980", "8790599", "15911030", "10551376", "8554902", "10669330", "12429528", "15746245", "1340770", "9150141", "9660950", "9096323", "15642694", "11931769", "11564889", "1508666", "8493089", "12213807", "9108029", "9003388", "1903539", "16438940", "10393859", "9764907", "10792382", "9353347", "15122352", "12213588", "8344262", "8605881", "9407026", "8557193", "9556555", "10454583", "10970736", "11044097", "14673171", "11909519", "15003270", "15299018", "8990153", "15114340", "15719058", "16280076", "8612591", "9405375", "7533895", "7885450", "10428772", "11331764", "11507198", "11545735", "9407024", "9407025", "12067656", "14731395", "9581978", "10916156", "11940650", "8900211", "10733565", "10199401", "9857195", "7929341", "10385623", "7797476", "8759772", "12721286", "12351650", "8423790", "8995607", "9973611", "11907272", "2470647", "2249668", "1907891", "8450553", "1621097", "7563092", "8918800", "8041622", "9108013", "12857725", "9473010", "9614214", "15105155", "10995220", "10069377", "15095977", "12356320", "15723535", "1942253", "8871552", "12376617", "12438622", "12588988", "15653695", "7537216", "7583436", "9117450", "12401780", "10328810", "3181132", "2535718", "2536828", "9188504", "15722166", "1279199", "1617647", "8416373", "9378998", "7539135", "8249283", "7853496", "9334325", "10438593", "12052871", "10866664", "10066804", "11572868", "11112772", "11145967", "11809800", "11940650", "14701750", "9491887", "9832504", "9843510", "11713532", "11713533", "12832472", "15201869", "14580347", "15169877", "15855166", "10906320", "11461999", "15531588", "12049628", "12114499", "10958691", "10913173", "8849451", "11780068", "9315662", "11604498", "15485897", "15905409", "11278368", "12408826", "14569024", "9822634", "10938286", "15723517", "12185079", "12788939", "8607265", "9388189", "11959860", "9751712", "11384967", "9733796", "9811832", "9733868", "10545121", "12486002", "10607594", "12887902", "9121429", "12126615", "11931765", "12032084", "9561563", "15383533", "15719057", "12883554", "15596808"], "citedInPMID": ["16838299", "33805800", "33201954", "32929000", "31534649", "28798862", "28004925", "25731772", "25323821", "25136641", "24832514", "24156270", "23412370", "23274668", "22904091", "22567366", "22334708", "22294645", "22003984", "21762475", "21371997", "21228755", "21221075", "20875428", "20828615", "20542430", "20486932", "20380694", "20048049", "19896372", "19726504", "19584251", "19503603", "19364391", "19301659", "19052666", "18996020", "18086892", "17263584", "17242146"], "body": " AbstractThe regulation of transcription of the human immunodeficiency virus (HIV) is a complex event that requires the cooperative action of both viral and cellular components. In latently infected resting CD4+ T cells HIV\u20101 transcription seems to be repressed by deacetylation events mediated by histone deacetylases (HDACs). Upon reactivation of HIV\u20101 from latency, HDACs are displaced in response to the recruitment of histone acetyltransferases (HATs) by NF\u2010\u03baB or the viral transcriptional activator Tat and result in multiple acetylation events. Following chromatin remodeling of the viral promoter region, transcription is initiated and leads to the formation of the TAR element. The complex of Tat with p\u2010TEFb then binds the loop structures of TAR RNA thereby positioning CDK9 to phosphorylate the cellular RNA polymerase II. The Tat\u2010TAR\u2010dependent phosphorylation of RNA polymerase II plays an important role in transcriptional elongation as well as in other post\u2010transcriptional events. As such, targeting of Tat protein (and/or cellular cofactors) provide an interesting perspective for therapeutic intervention in the HIV replicative cycle and may afford lifetime control of the HIV infection. \u00a9 2006 Wiley Periodicals, Inc. Med Res Rev, 26, No. 5, 595\u2013625, 2006Keywords: HIV\u20101, LTR, transcription, latency, NF\u2010\u03baB, Tat, TAR, RNA polymerase II REFERENCES1. \nDasgupta P,\nSaikumar P,\nReddy CD,\nReddy EP.\nMyb protein binds to human immunodeficiency virus 1 long terminal repeat (LTR) sequences and transactivates LTR\u2010mediated transcription.\nProc Natl Acad Sci USA\n1990;\n87:\n8090\u20138094.\n [PMC free article] [PubMed] [Google Scholar]2. \nSeth A,\nHodge DR,\nThompson DM,\nRobinson L,\nPanayiotakis A,\nWatson DK,\nPapas TS.\nETS family proteins activate transcription from HIV\u20101 long terminal repeat.\nAIDS Res Hum Retroviruses\n1993;\n9:\n1017\u20131023.\n [PubMed] [Google Scholar]3. \nLu YC,\nTouzjian N,\nStenzel M,\nDorfman T,\nSodroski JG,\nHaseltine WA.\nIdentification of cis\u2010acting repressive sequences within the negative regulatory element of human immunodeficiency virus type 1.\nJ Virol\n1990;\n64:\n5226\u20135229.\n [PMC free article] [PubMed] [Google Scholar]4. \nShaw JP,\nUtz PJ,\nDurand DB,\nToole JJ,\nEmmel EA,\nCrabtree GR.\nIdentification of a putative regulator of early T cell activation genes.\nScience\n1988;\n241:\n202\u2013205.\n [PubMed] [Google Scholar]5. \nHenderson AJ,\nZou X,\nCalame KL.\nC/EBP proteins activate transcription from the human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes.\nJ Virol\n1995;\n69:\n5337\u20135344.\n [PMC free article] [PubMed] [Google Scholar]6. \nFranza BR,\nRauscher FJ,\nJosephs SF,\nCurran T.\nThe Fos complex and Fos\u2010related antigens recognize sequence elements that contain AP\u20101 binding sites.\nScience\n1988;\n239:\n1150\u20131153.\n [PubMed] [Google Scholar]7. \nSheridan PL,\nSheline CT,\nCannon K,\nVoz ML,\nPazin MJ,\nKadonaga JT,\nJones KA.\nActivation of the HIV\u20101 enhancer by the LEF\u20101 HMG protein on nucleosome\u2010assembled DNA in vitro.\nGenes Dev\n1995;\n9:\n2090\u20132104.\n [PubMed] [Google Scholar]8. \nGhosh H.\nGlucocorticoid receptor\u2010binding site in the human immunodeficiency virus long terminal repeat.\nJ Virol\n1992;\n66:\n586\u2013590.\n [PMC free article] [PubMed] [Google Scholar]9. \nLee MO,\nHobbs PD,\nZhang XK,\nDawson MI,\nPfahl M.\nA synthetic retinoid antagonist inhibits the human immunodeficiency virus type 1 promoter.\nProc Natl Acad Sci USA\n1994;\n91:\n5632\u20135636.\n [PMC free article] [PubMed] [Google Scholar]10. \nCooney AJ,\nTsai SY,\nO'Malley BW,\nTsai MJ.\nChicken ovalbumin upstream promoter transcription factor binds to a negative regulatory region in the human immunodeficiency virus type 1 long terminal repeat.\nJ Virol\n1991;\n65:\n2853\u20132860.\n [PMC free article] [PubMed] [Google Scholar]11. \nLee MO,\nDawson MI,\nPicard N,\nHobbs PD,\nPfahl M.\nA novel class of retinoid antagonists and their mechanism of action.\nJ Biol Chem\n1996;\n271:\n11897\u201311903.\n [PubMed] [Google Scholar]12. \nDickinson LA,\nGulizia RJ,\nTrauger JW,\nBaird EE,\nMosier DE,\nGottesfeld JM,\nDervan PB.\nInhibition of RNA polymerase II transcription in human cells by synthetic DNA\u2010binding ligands.\nProc Natl Acad Sci USA\n1998;\n95:\n12890\u201312895.\n [PMC free article] [PubMed] [Google Scholar]13. \nTravis A,\nAmsterdam A,\nBelanger C,\nGrosschedl R.\nLEF\u20101, a gene encoding a lymphoid\u2010specific protein with an HMG domain, regulates T\u2010cell receptor alpha enhancer function.\nGenes Dev\n1991;\n5:\n880\u2013894.\n [PubMed] [Google Scholar]14. \nGiese K,\nCox J,\nGrosschedl R.\nThe HMG domain of lymphoid enhancer factor 1 bends DNA and facilitates assembly of functional nucleoprotein structures.\nCell\n1992;\n69:\n185\u2013195.\n [PubMed] [Google Scholar]15. \nd'Adda di Fagagna F,\nMarzio G,\nGutierrez MI,\nKang LY,\nFalaschi A,\nGiacca M.\nMolecular and functional interactions of transcription factor USF with the long terminal repeat of human immunodeficiency virus type 1.\nJ Virol\n1995;\n69:\n2765\u20132775.\n [PMC free article] [PubMed] [Google Scholar]16. \nDickinson LA,\nTrauger JW,\nBaird EE,\nDervan PB,\nGraves BJ,\nGottesfeld JM.\nInhibition of Ets\u20101 DNA binding and ternary complex formation between Ets\u20101, NF\u2010kappaB, and DNA by a designed DNA\u2010binding ligand.\nJ Biol Chem\n1999;\n274:\n12765\u201312773.\n [PubMed] [Google Scholar]17. \nPerkins ND,\nAgranoff AB,\nDuckett CS,\nNabel GJ.\nTranscription factor AP\u20102 regulates human immunodeficiency virus type 1 gene expression.\nJ Virol\n1994;\n68:\n6820\u20136823.\n [PMC free article] [PubMed] [Google Scholar]18. \nvan Opijnen T,\nKamoschinski J,\nJeeninga RE,\nBerkhout B.\nThe human immunodeficiency virus type 1 promoter contains a CATA box instead of a TATA box for optimal transcription and replication.\nJ Virol\n2004;\n78:\n6883\u20136890.\n [PMC free article] [PubMed] [Google Scholar]19. \nHarrich D,\nGarcia J,\nWu F,\nMitsuyasu R,\nGonazalez J,\nGaynor R.\nRole of SP1\u2010binding domains in in vivo transcriptional regulation of the human immunodeficiency virus type 1 long terminal repeat.\nJ Virol\n1989; \n63:\n2585\u20132591.\n [PMC free article] [PubMed] [Google Scholar]20. \nKato H,\nHorikoshi M,\nRoeder RG.\nRepression of HIV\u20101 transcription by a cellular protein.\nScience\n1991;\n251:\n1476\u20131479.\n [PubMed] [Google Scholar]21. \nParada CA,\nYoon JB,\nRoeder RG.\nA novel LBP\u20101\u2010mediated restriction of HIV\u20101 transcription at the level of elongation in vitro.\nJ Biol Chem\n1995;\n270:\n2274\u20132283.\n [PubMed] [Google Scholar]22. \nRomerio F,\nGabriel MN,\nMargolis DM.\nRepression of human immunodeficiency virus type 1 through the novel cooperation of human factors YY1 and LSF.\nJ Virol\n1997;\n71:\n9375\u20139382.\n [PMC free article] [PubMed] [Google Scholar]23. \nCoull JJ,\nRomerio F,\nSun JM,\nVolker JL,\nGalvin KM,\nDavie JR,\nShi Y,\nHansen U,\nMargolis DM.\nThe human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1.\nJ Virol\n2000;\n74:\n6790\u20136799.\n [PMC free article] [PubMed] [Google Scholar]24. \nHe G,\nMargolis DM.\nCounterregulation of chromatin deacetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 (HIV\u20101) by the HIV\u20101 repressor YY1 and HIV\u20101 activator Tat.\nMol Cell Biol\n2002;\n22:\n2965\u20132973.\n [PMC free article] [PubMed] [Google Scholar]25. \nCoull JJ,\nHe G,\nMelander C,\nRucker VC,\nDervan PB,\nMargolis DM.\nTargeted derepression of the human immunodeficiency virus type 1 long terminal repeat by pyrrole\u2010imidazole polyamides.\nJ Virol\n2002;\n76:\n12349\u201312354.\n [PMC free article] [PubMed] [Google Scholar]26. \nYlisastigui L,\nKaur R,\nJohnson H,\nVolker J,\nHe G,\nHansen U,\nMargolis D.\nMitogen\u2010activated protein kinases regulate LSF occupancy at the human immunodeficiency virus type 1 promoter.\nJ Virol\n2005;\n79:\n5952\u20135962.\n [PMC free article] [PubMed] [Google Scholar]27. \nOu SH,\nWu F,\nHarrich D,\nGarcia\u2010Martinez LF,\nGaynor RB.\nCloning and characterization of a novel cellular protein, TDP\u201043, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs.\nJ Virol\n1995;\n69:\n3584\u20133596.\n [PMC free article] [PubMed] [Google Scholar]28. \nDu H,\nRoy AL,\nRoeder RG.\nHuman transcription factor USF stimulates transcription through the initiator elements of the HIV\u20101 and the Ad\u2010ML promoters.\nEMBO J\n1993;\n12:\n501\u2013511.\n [PMC free article] [PubMed] [Google Scholar]29. \nRatnasabapathy R,\nSheldon M,\nJohal L,\nHernandez N.\nThe HIV\u20101 long terminal repeat contains an unusual element that induces the synthesis of short RNAs from various mRNA and snRNA promoters.\nGenes Dev\n1990;\n4:\n2061\u20132074.\n [PubMed] [Google Scholar]30. \nPessler F,\nPendergrast PS,\nHernandez N.\nPurification and characterization of FBI\u20101, a cellular factor that binds to the human immunodeficiency virus type 1 inducer of short transcripts.\nMol Cell Biol\n1997;\n17:\n3786\u20133798.\n [PMC free article] [PubMed] [Google Scholar]31. \nVan Lint C,\nAmella CA,\nEmiliani S,\nJohn M,\nJie T,\nVerdin E.\nTranscription factor binding sites downstream of the human immunodeficiency virus type 1 transcription start site are important for virus infectivity.\nJ Virol\n1997;\n71:\n6113\u20136127.\n [PMC free article] [PubMed] [Google Scholar]32. \nMallardo M,\nDragonetti E,\nBaldassarre F,\nAmbrosino C,\nScala G,\nQuinto I.\nAn NF\u2010kappaB site in the 5\u2032\u2010untranslated leader region of the human immunodeficiency virus type 1 enhances the viral expression in response to NF\u2010kappaB\u2010activating stimuli.\nJ Biol Chem\n1996;\n271:\n20820\u201320827.\n [PubMed] [Google Scholar]33. \nSgarbanti M,\nBorsetti A,\nMoscufo N,\nBellocchi MC,\nRidolfi B,\nNappi F,\nMarsili G,\nMarziali G,\nCoccia EM,\nEnsoli B,\nBattistini A.\nModulation of human immunodeficiency virus 1 replication by interferon regulatory factors.\nJ Exp Med\n2002;\n195:\n1359\u20131370.\n [PMC free article] [PubMed] [Google Scholar]34. \nMarsili G,\nRemoli AL,\nSgarbanti M,\nBattistini A.\nRole of acetylases and deacetylase inhibitors in IRF\u20101\u2010mediated HIV\u20101 long terminal repeat transcription.\nAnn NY Acad Sci\n2004;\n1030:\n636\u2013643.\n [PubMed] [Google Scholar]35. \nBattistini A,\nMarsili G,\nSgarbanti M,\nEnsoli B,\nHiscott J.\nIRF regulation of HIV\u20101 long terminal repeat activity.\nJ Interferon Cytokine Res\n2002;\n22:\n27\u201337.\n [PubMed] [Google Scholar]36. \nNabel G,\nBaltimore D.\nAn inducible transcription factor activates expression of human immunodeficiency virus in T cells.\nNature\n1987;\n326:\n711\u2013713.\n [PubMed] [Google Scholar]37. \nSchreck R,\nRieber P,\nBaeuerle PA.\nReactive oxygen intermediates as apparently widely used messengers in the activation of the NF\u2010kappa B transcription factor and HIV\u20101.\nEMBO J\n1991;\n10:\n2247\u20132258.\n [PMC free article] [PubMed] [Google Scholar]38. \nSchreck R,\nMeier B,\nMannel DN,\nDroge W,\nBaeuerle PA.\nDithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells.\nJ Exp Med\n1992;\n175:\n1181\u20131194.\n [PMC free article] [PubMed] [Google Scholar]39. \nRoederer M,\nStaal FJ,\nRaju PA,\nEla SW,\nHerzenberg LA,\nHerzenberg LA.\nCytokine\u2010stimulated human immunodeficiency virus replication is inhibited by N\u2010acetyl\u2010L\u2010cysteine.\nProc Natl Acad Sci USA\n1990;\n87:\n4884\u20134888.\n [PMC free article] [PubMed] [Google Scholar]40. \nBowie A,\nO' Neill AJ.\nOxidative stress and nuclear factor\u2010\u03baB activation.\nBiochem Pharmacol\n2002;\n59:\n13\u201323.\n [PubMed] [Google Scholar]41. \nStaal FJ,\nRoederer M,\nHerzenberg LA,\nHerzenberg LA.\nIntracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus.\nProc Natl Acad Sci USA\n1990;\n87:\n9943\u20139947.\n [PMC free article] [PubMed] [Google Scholar]42. \nWhiteside ST,\nIsrael A.\nI kappa B proteins: Structure, function and regulation.\nSemin Cancer Biol\n1997; \n8:\n75\u201382.\n [PubMed] [Google Scholar]43. \nSakurai H,\nChiba H,\nMiyoshi H,\nSugita T,\nToriumi W.\nIkappaB kinases phosphorylate NF\u2010kappaB p65 subunit on serine 536 in the transactivation domain.\nJ Biol Chem\n1999;\n274:\n30353\u201330356.\n [PubMed] [Google Scholar]44. \nMattioli I,\nSebald A,\nBucher C,\nCharles RP,\nNakano H,\nDoi T,\nKracht M,\nSchmitz ML.\nTransient and selective NF\u2010kappa B p65 serine 536 phosphorylation induced by T cell costimulation is mediated by I kappa B kinase beta and controls the kinetics of p65 nuclear import.\nJ Immunol\n2004;\n172:\n6336\u20136344.\n [PubMed] [Google Scholar]45. \nLee R,\nBeauparlant P,\nElford H,\nPonka P,\nHiscott J.\nSelective inhibition of I kappaB alpha phosphorylation and HIV\u20101 LTR\u2010directed gene expression by novel antioxidant compounds.\nVirology\n1997;\n234:\n277\u2013290.\n [PubMed] [Google Scholar]46. \nBaur A,\nHarrer T,\nPeukert M,\nJahn G,\nKalden JR,\nFleckenstein B.\nAlpha\u2010lipoic acid is an effective inhibitor of human immunodeficiency virus (HIV\u20101) replication.\nKlin Wochenschr\n1991;\n69:\n722\u2013724.\n [PubMed] [Google Scholar]47. \nSuzuki YJ,\nAggarwal BB,\nPacker L.\nAlpha\u2010lipoic acid is a potent inhibitor of NF\u2010kappa B activation in human T cells.\nBiochem Biophys Res Commun\n1992;\n189:\n1709\u20131715.\n [PubMed] [Google Scholar]48. \nProchaska HJ,\nYeh Y,\nBaron P,\nPolsky B.\nOltipraz, an inhibitor of human immunodeficiency virus type 1 replication.\nProc Natl Acad Sci USA\n1993;\n90:\n3953\u20133957.\n [PMC free article] [PubMed] [Google Scholar]49. \nProchaska HJ,\nBornmann WG,\nBaron P,\nPolsky B.\nInhibition of human immunodeficiency virus type 1 replication by 7\u2010methyl\u20106,8\u2010bis(methylthio)pyrrolo[1,2\u2010a]pyrazine, an in vivo metabolite of oltipraz.\nMol Pharmacol\n1997;\n48:\n15\u201320.\n [PubMed] [Google Scholar]50. \nIsrael N,\nGougerot\u2010Pocidalo MA,\nAillet F,\nVirelizier JL.\nRedox status of cells influences constitutive or induced NF\u2010kappa B translocation and HIV long terminal repeat activity in human T and monocytic cell lines.\nJ Immunol\n1992;\n149:\n3386\u20133393.\n [PubMed] [Google Scholar]51. \nKopp E,\nGhosh S.\nInhibition of NF\u2010\u03baB by sodium salicylate and aspirin.\nScience\n1994;\n265:\n956\u2013959.\n [PubMed] [Google Scholar]52. \nBiswas DK,\nDezube BJ,\nAhlers CM,\nPardee AB.\nPentoxifylline inhibits HIV\u20101 LTR\u2010driven gene expression by blocking NF\u2010kappa B action.\nJ Acquir Immune Defic Syndr\n1993;\n6:\n778\u2013786.\n [PubMed] [Google Scholar]53. \nBiswas DK,\nAhlers CM,\nDezube BJ,\nPardee AB.\nPentoxifylline and other protein kinase C inhibitors down\u2010regulate HIV\u2010LTR NF\u2010kappa B induced gene expression.\nMol Med\n1994;\n1:\n31\u201343.\n [PMC free article] [PubMed] [Google Scholar]54. \nMarquez N,\nSancho R,\nBedoya LM,\nAlcami J,\nLopez\u2010Perez JL,\nFeliciano AS,\nFiebich BL,\nMunoz E.\nMesuol, a natural occurring 4\u2010phenylcoumarin, inhibits HIV\u20101 replication by targeting the NF\u2010kappaB pathway.\nAntiviral Res\n2005;\n66:\n137\u2013145.\n [PubMed] [Google Scholar]55. \nFujiwara M,\nOkamoto M,\nOkamoto M,\nWatanabe M,\nMachida H,\nShigeta S,\nKonno K,\nYokota T,\nBaba M.\nAcridone derivatives are selective inhibitors of HIV\u20101 replication in chronically infected cells.\nAntiviral Res\n1999;\n43:\n189\u2013199.\n [PubMed] [Google Scholar]56. \nSappey C,\nBoelaert JR,\nLegrand\u2010Poels S,\nForceille C,\nFavier A,\nPiette J.\nIron chelation decreases NF\u2010kappa B and HIV type 1 activation due to oxidative stress.\nAIDS Res Hum Retroviruses\n1995;\n11:\n1049\u20131061.\n [PubMed] [Google Scholar]57. \nGeorgiou NA,\nvan der Bruggen T,\nOudshoorn M,\nNottet HS,\nMarx JJ,\nvan Asbeck BS.\nInhibition of human immunodeficiency virus type 1 replication in human mononuclear blood cells by the iron chelators deferoxamine, deferiprone, and bleomycin.\nJ Infect Dis\n2000;\n181:\n484\u2013490.\n [PubMed] [Google Scholar]58. \nIordanskiy S,\nIordanskaya T,\nQuivy V,\nVan Lint C,\nBukrinsky M.\nB\u2010oligomer of pertussis toxin inhibits HIV\u20101 LTR\u2010driven transcription through suppression of NF\u2010kappaB p65 subunit activity.\nVirology\n2002;\n302:\n195\u2013206.\n [PubMed] [Google Scholar]59. \nLapenta C,\nSpada M,\nSantini SM,\nRacca S,\nDorigatti F,\nPoli G,\nBelardelli F,\nAlfano M.\nPertussis toxin B\u2010oligomer inhibits HIV infection and replication in hu\u2010PBL\u2010SCID mice.\nInt Immunol\n2005;\n17:\n469\u2013475.\n [PubMed] [Google Scholar]60. \nBeg AA,\nRuben SM,\nScheinman RI,\nHaskill S,\n\nRosen\nCA, Jr.\n,\nBaldwin AS.\nI kappa B interacts with the nuclear localization sequences of the subunits of NF\u2010kappa B: A mechanism for cytoplasmic retention.\nGenes Dev\n1992;\n6:\n1899\u20131913.\n [PubMed] [Google Scholar]61. \nZhong H,\nSuYang H,\nErdjument\u2010Bromage H,\nTempst P,\nGhosh S.\nThe transcriptional activity of NF\u2010kappaB is regulated by the IkappaB\u2010associated PKAc subunit through a cyclic AMP\u2010independent mechanism.\nCell\n1997;\n89:\n413\u2013424.\n [PubMed] [Google Scholar]62. \nZhong H,\nVoll RE,\nGhosh S.\nPhosphorylation of NF\u2010kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300.\nMol Cell\n1998;\n1:\n661\u2013671.\n [PubMed] [Google Scholar]63. \nGerritsen ME,\nWilliams AJ,\nNeish AS,\nMoore S,\nShi Y,\nCollins T.\nCREB\u2010binding protein/p300 are transcriptional coactivators of p65.\nProc Natl Acad Sci USA\n1997;\n94:\n2927\u20132932.\n [PMC free article] [PubMed] [Google Scholar]64. \nGuan H,\nHou S,\nRicciardi RP.\nDNA binding of repressor nuclear factor\u2010kappaB p50/p50 depends on phosphorylation of Ser337 by the protein kinase A catalytic subunit.\nJ Biol Chem\n2005;\n280:\n9957\u20139962.\n [PubMed] [Google Scholar]65. \nZhong H,\nMay MJ,\nJimi E,\nGhosh S.\nThe phosphorylation status of nuclear NF\u2010kappa B determines its association with CBP/p300 or HDAC\u20101.\nMol Cell\n2002;\n9:\n625\u2013636.\n [PubMed] [Google Scholar]66. \nAshburner BP,\n\nWesterheide\nSD, Jr.\n,\nBaldwin AS.\nThe p65 (RelA) subunit of NF\u2010kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression.\nMol Cell Biol\n2001;\n21:\n7065\u20137077.\n [PMC free article] [PubMed] [Google Scholar]67. \nMatthews JR,\nWakasugi N,\nVirelizier JL,\nYodoi J,\nHay RT.\nThioredoxin regulates the DNA binding activity of NF\u2010kappa B by reduction of a disulphide bond involving cysteine 62.\nNucleic Acids Res\n1992;\n20:\n3821\u20133830.\n [PMC free article] [PubMed] [Google Scholar]68. \nMatthews JR,\nKaszubska W,\nTurcatti G,\nWells TN,\nHay RT.\nRole of cysteine 62 in DNA recognition by the p50 subunit of NF\u2010kappa B.\nNucleic Acids Res\n1993;\n21:\n1727\u20131734.\n [PMC free article] [PubMed] [Google Scholar]69. \nNishi T,\nShimizu N,\nHiramoto M,\nSato I,\nYamaguchi Y,\nHasegawa M,\nAizawa S,\nTanaka H,\nKataoka K,\nWatanabe H,\nHanda H.\nSpatial redox regulation of a critical cysteine residue of NF\u2010kappa B in vivo.\nJ Biol Chem\n2002;\n277:\n44548\u201344556.\n [PubMed] [Google Scholar]70. \nHirota K,\nMatsui M,\nIwata S,\nNishiyama A,\nMori K,\nYodoi J.\nAP\u20101 transcriptional activity is regulated by a direct association between thioredoxin and Ref\u20101.\nProc Natl Acad Sci USA\n1997;\n94:\n3633\u20133638.\n [PMC free article] [PubMed] [Google Scholar]71. \nBrennan P,\nO'Neill LA.\n2\u2010mercaptoethanol restores the ability of nuclear factor kappa B (NF kappa B) to bind DNA in nuclear extracts from interleukin 1\u2010treated cells incubated with pyrollidine dithiocarbamate (PDTC). Evidence for oxidation of glutathione in the mechanism of inhibition of NF kappa B by PDTC.\nBiochem J\n1996;\n320:\n975\u2013981.\n [PMC free article] [PubMed] [Google Scholar]72. \nToledano MB,\nLeonard WJ.\nModulation of transcription factor NF\u2010kappa B binding activity by oxidation\u2010reduction in vitro.\nProc Natl Acad Sci USA\n1991;\n88:\n4328\u20134332.\n [PMC free article] [PubMed] [Google Scholar]73. \nStevens M,\nPannecouque C,\nDe Clercq E,\nBalzarini J.\nPyridine N\u2010oxide derivatives inhibit viral transactivation by interfering with NF\u2010\u03baB binding.\nBiochem Pharmacol\n2006;\n71:\n1122\u20131135.\n [PubMed] [Google Scholar]74. \nChen F,\nLu Y,\nCastranova V,\nRojanasakul Y,\nMiyahara K,\nShizuta Y,\nVallyathan V,\nShi X,\nDemers LM.\nNitric oxide inhibits HIV Tat\u2010induced NF\u2010kappaB activation.\nAm J Pathol\n1999;\n155:\n275\u2013284.\n [PMC free article] [PubMed] [Google Scholar]75. \nOkamoto M,\nOno M,\nBaba M.\nPotent inhibition of HIV type 1 replication by an antiinflammatory alkaloid, cepharanthine, in chronically infected monocytic cells.\nAIDS Res Hum Retroviruses\n1998;\n14:\n1239\u20131245.\n [PubMed] [Google Scholar]76. \nCalzado MA,\nMacHo A,\nLucena C,\nMunoz E.\nHydroxyurea inhibits the transactivation of the HIV\u2010long\u2010terminal repeat (LTR) promoter.\nClin Exp Immunol\n2000;\n120:\n317\u2013323.\n [PMC free article] [PubMed] [Google Scholar]77. \nYasui H,\nButscher W,\nCohen M,\nSpriggs N,\nWersto R,\nKohn EC,\nLiotta L,\nGardner K.\nSelective inhibition of mitogen\u2010induced transactivation of the HIV long terminal repeat by carboxyamidotriazole. Calcium influx blockade represses HIV\u20101 transcriptional activation.\nJ Biol Chem\n1997;\n272:\n28762\u201328770.\n [PubMed] [Google Scholar]78. \nChen LF,\nGreene WC.\nShaping the nuclear action of NF\u2010\u03baB.\nNat Rev Mol Cell Biol\n2004;\n5:\n392\u2013401.\n [PubMed] [Google Scholar]79. \nQuivy V,\nVan Lint C.\nDiversity of acetylation targets and roles in transcriptional regulation: The human immunodeficiency virus type 1 promoter as a model system.\nBiochem Pharmacol\n2002;\n64:\n925\u2013934.\n [PubMed] [Google Scholar]80. \nVerdin E,\n\nParas\nP, Jr.\n,\nVan Lint C.\nChromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation.\nEMBO J\n1993;\n12:\n3249\u20133259.\n [PMC free article] [PubMed] [Google Scholar]81. \nVan Lint C,\nEmiliani S,\nOtt M,\nVerdin E.\nTranscriptional activation and chromatin remodeling of the HIV\u20101 promoter in response to histone acetylation.\nEMBO J\n1996;\n15:\n1112\u20131120.\n [PMC free article] [PubMed] [Google Scholar]82. \nSheridan PL,\nMayall TP,\nVerdin E,\nJones KA.\nHistone acetyltransferases regulate HIV\u20101 enhancer activity in vitro.\nGenes Dev\n1997;\n11:\n3327\u20133340.\n [PMC free article] [PubMed] [Google Scholar]83. \nPazin MJ,\nSheridan PL,\nCannon K,\nCao Z,\nKeck JG,\nKadonaga JT,\nJones KA.\nNF\u2010kappa B\u2010mediated chromatin reconfiguration and transcriptional activation of the HIV\u20101 enhancer in vitro.\nGenes Dev\n1996;\n10:\n37\u201349.\n [PubMed] [Google Scholar]84. \nNa SY,\nLee SK,\nHan SJ,\nChoi HS,\nIm SY,\nLee JW.\nSteroid receptor coactivator\u20101 interacts with the p50 subunit and coactivates nuclear factor kappaB\u2010mediated transactivations.\nJ Biol Chem\n1998;\n273:\n10831\u201310834.\n [PubMed] [Google Scholar]85. \nSheppard KA,\nRose DW,\nHaque ZK,\nKurokawa R,\nMcInerney E,\nWestin S,\nThanos D,\nRosenfeld MG,\nGlass CK,\nCollins T.\nTranscriptional activation by NF\u2010kappaB requires multiple coactivators.\nMol Cell Biol\n1999;\n19:\n6367\u20136378.\n [PMC free article] [PubMed] [Google Scholar]86. \nAngelov D,\nCharra M,\nSeve M,\nCote J,\nKhochbin S,\nDimitrov S.\nDifferential remodeling of the HIV\u20101 nucleosome upon transcription activators and SWI/SNF complex binding.\nJ Mol Biol\n2002;\n302:\n315\u2013326.\n [PubMed] [Google Scholar]87. \nHenderson A,\nBunce M,\nSiddon N,\nReeves R,\nTremethick DJ.\nHigh\u2010mobility\u2010group protein I can modulate binding of transcription factors to the U5 region of the human immunodeficiency virus type 1 proviral promoter.\nJ Virol\n2002;\n74:\n10523\u201310534.\n [PMC free article] [PubMed] [Google Scholar]88. \nHenderson A,\nHolloway A,\nReeves R,\nTremethick DJ.\nRecruitment of SWI/SNF to the human immunodeficiency virus type 1 promoter.\nMol Cell Biol\n2004;\n24:\n389\u2013397.\n [PMC free article] [PubMed] [Google Scholar]89. \nNarlikar GJ,\nFan HY,\nKingston RE.\nCooperation between complexes that regulate chromatin structure and transcription.\nCell\n2002;\n108:\n475\u2013487.\n [PubMed] [Google Scholar]90. \nStuditsky VM,\nWalter W,\nKireeva M,\nKashlev M,\nFelsenfeld G.\nChromatin remodeling by RNA polymerases.\nTrends Biochem Sci\n2004;\n29:\n127\u2013135.\n [PubMed] [Google Scholar]91. \nKiefer HLB,\nHanley TM,\nMarcello JE,\nKarthik AG,\nViglianti GA.\nRetinoic acid inhibition of chromatin remodeling at the human immunodeficiency virus type 1 promoter.\nJ Biol Chem\n2004;\n279:\n43604\u201343613.\n [PubMed] [Google Scholar]92. \nNikolov DB,\nBurley SK.\nRNA polymerase II transcription initiation: A structural view.\nProc Natl Acad Sci USA\n1997;\n94:\n15\u201322.\n [PMC free article] [PubMed] [Google Scholar]93. \nHahn S.\nStructure and mechanism of the RNA polymerase II transcription machinery.\nNat Struct Mol Biol\n2004;\n11:\n394\u2013403.\n [PMC free article] [PubMed] [Google Scholar]94. \nRaha T,\nCheng SW,\nGreen MR.\nHIV\u20101 Tat stimulates transcription complex assembly through recruitment of TBP in the absence of TAFs.\nPLoS Biol\n2005;\n3:\ne44.\n [PMC free article] [PubMed] [Google Scholar]95. \nBrady J,\nKashanchi F.\nTat gets the \u201cgreen\u201d light on transcription initiation.\nRetrovirology\n2005;\n2:\n69.\n [PMC free article] [PubMed] [Google Scholar]96. \nHolstege FC,\nvan der Vliet PC,\nTimmers HT.\nOpening of an RNA polymerase II promoter occurs in two distinct steps and requires the basal transcription factors IIE and IIH.\nEMBO J\n1996;\n15:\n1666\u20131677.\n [PMC free article] [PubMed] [Google Scholar]97. \nHolstege FC,\nFiedler U,\nTimmers HT.\nThree transitions in the RNA polymerase II transcription complex during initiation.\nEMBO J\n1997;\n16:\n7468\u20137480.\n [PMC free article] [PubMed] [Google Scholar]98. \nShiekhattar R,\nMermelstein F,\nFisher RP,\nDrapkin R,\nDynlacht B,\nWessling HC,\nMorgan DO,\nReinberg D.\nCdk\u2010activating kinase complex is a component of human transcription factor TFIIH.\nNature\n1995;\n374:\n283\u2013287.\n [PubMed] [Google Scholar]99. \nSerizawa H,\nMakela TP,\nConaway JW,\nConaway RC,\nWeinberg RA,\nYoung RA.\nAssociation of Cdk\u2010activating kinase subunits with transcription factor TFIIH.\nNature\n1995;\n374:\n280\u2013282.\n [PubMed] [Google Scholar]100. \nMoreland RJ,\nTirode F,\nYan Q,\nConaway JW,\nEgly JM,\nConaway RC.\nA role for the TFIIH XPB DNA helicase in promoter escape by RNA polymerase II.\nJ Biol Chem\n1999;\n274:\n22127\u201322130.\n [PubMed] [Google Scholar]101. \nSpangler L,\nWang X,\nConaway JW,\nConaway RC,\nDvir A.\nTFIIH action in transcription initiation and promoter escape requires distinct regions of downstream promoter DNA.\nProc Natl Acad Sci USA\n2001;\n98:\n5544\u20135549.\n [PMC free article] [PubMed] [Google Scholar]102. \nWest MJ,\nLowe AD,\nKarn J.\nActivation of human immunodeficiency virus transcription in T cells revisited: NF\u2010kappaB p65 stimulates transcriptional elongation.\nJ Virol\n2001;\n75:\n8524\u20138537.\n [PMC free article] [PubMed] [Google Scholar]103. \nBarboric M,\nNissen RM,\nKanazawa S,\nJabrane\u2010Ferrat N,\nPeterlin BM.\nNF\u2010kappaB binds P\u2010TEFb to stimulate transcriptional elongation by RNA polymerase II.\nMol Cell\n2001;\n8:\n327\u2013337.\n [PubMed] [Google Scholar]104. \nMcCracken S,\nFong N,\nRosonina E,\nYankulov K,\nBrothers G,\nSiderovski D,\nHessel A,\nFoster S,\nShuman S,\nBentley DL.\n5\u2032\u2010Capping enzymes are targeted to pre\u2010mRNA by binding to the phosphorylated carboxy\u2010terminal domain of RNA polymerase II.\nGenes Dev\n1997;\n11:\n3306\u20133318.\n [PMC free article] [PubMed] [Google Scholar]105. \nCho EJ,\nTakagi T,\nMoore CR,\nBuratowski S.\nmRNA capping enzyme is recruited to the transcription complex by phosphorylation of the RNA polymerase II carboxy\u2010terminal domain.\nGenes Dev\n1997; \n11:\n3319\u20133326.\n [PMC free article] [PubMed] [Google Scholar]106. \nBentley D.\nThe mRNA assembly line: Transcription and processing machines in the same factory.\nCurr Opin Cell Biol\n2002;\n14:\n336\u2013342.\n [PubMed] [Google Scholar]107. \nAhn SH,\nKim M,\nBuratowski S.\nPhosphorylation of serine 2 within the RNA polymerase II C\u2010terminal domain couples transcription and 3\u2032 end processing.\nMol Cell\n2004;\n13:\n67\u201376.\n [PubMed] [Google Scholar]108. \nYamaguchi Y,\nWada T,\nHanda H.\nInterplay between positive and negative elongation factors: Drawing a new view of DRB.\nGenes Cells\n1998;\n3:\n9\u201315.\n [PubMed] [Google Scholar]109. \nConaway JW,\nShilatifard A,\nDvir A,\nConaway RC.\nControl of elongation by RNA polymerase II.\nTrends Biochem Sci\n2000;\n25:\n375\u2013380.\n [PubMed] [Google Scholar]110. \nYamaguchi Y,\nInukai N,\nNarita T,\nWada T,\nHanda H.\nEvidence that negative elongation factor represses transcription elongation through binding to a DRB sensitivity\u2010inducing factor/RNA polymerase II complex and RNA.\nMol Cell Biol\n2002;\n22:\n2918\u20132927.\n [PMC free article] [PubMed] [Google Scholar]111. \nMarshall NF,\nPeng J,\nXie Z,\nPrice DH.\nControl of RNA polymerase II elongation potential by a novel carboxyl\u2010terminal domain kinase.\nJ Biol Chem\n1996;\n271:\n27176\u201327183.\n [PubMed] [Google Scholar]112. \nPrice DH.\nP\u2010TEFb, a cyclin\u2010dependent kinase controlling elongation by RNA polymerase II.\nMol Cell Biol\n2000;\n20:\n2629\u20132634.\n [PMC free article] [PubMed] [Google Scholar]113. \nYamaguchi Y,\nTakagi T,\nWada T,\nYano K,\nFuruya A,\nSugimoto S,\nHasegawa J,\nHanda H.\nNELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation.\nCell\n1999;\n97:\n41\u201351.\n [PubMed] [Google Scholar]114. \nWada T,\nTakagi T,\nYamaguchi Y,\nWatanabe D,\nHanda H.\nEvidence that P\u2010TEFb alleviates the negative effect of DSIF on RNA polymerase II\u2010dependent transcription in vitro.\nEMBO J\n1998;\n17:\n7395\u20137403.\n [PMC free article] [PubMed] [Google Scholar]115. \nChambers RS,\nDahmus ME.\nPurification and characterization of a phosphatase from HeLa cells which dephosphorylates the C\u2010terminal domain of RNA polymerase II.\nJ Biol Chem\n1994;\n269:\n26243\u201326248.\n [PubMed] [Google Scholar]116. \nCho H,\nKim TK,\nMancebo H,\nLane WS,\nFlores O,\nReinberg D.\nA protein phosphatase functions to recycle RNA polymerase II.\nGenes Dev\n1999;\n13:\n1540\u20131552.\n [PMC free article] [PubMed] [Google Scholar]117. \nChambers RS,\nWang BQ,\nBurton ZF,\nDahmus ME.\nThe activity of COOH\u2010terminal domain phosphatase is regulated by a docking site on RNA polymerase II and by the general transcription factors IIF and IIB.\nJ Biol Chem\n1995;\n270:\n14962\u201314969.\n [PubMed] [Google Scholar]118. \nDahmus ME.\nReversible phosphorylation of the C\u2010terminal domain of RNA polymerase II.\nJ Biol Chem\n1996;\n271:\n19009\u201319012.\n [PubMed] [Google Scholar]119. \nYeo M,\nLin PS,\nDahmus ME,\nGill GN.\nA novel RNA polymerase II C\u2010terminal domain phosphatase that preferentially dephosphorylates serine 5.\nJ Biol Chem\n2003;\n278:\n26078\u201326085.\n [PubMed] [Google Scholar]120. \nLin PS,\nDubois MF,\nDahmus ME.\nTFIIF\u2010associating carboxyl\u2010terminal domain phosphatase dephosphorylates phosphoserines 2 and 5 of RNA polymerase II.\nJ Biol Chem\n2002;\n277:\n45949\u201345956.\n [PubMed] [Google Scholar]121. \nSheldon M,\nRatnasabapathy R,\nHernandez N.\nCharacterization of the inducer of short transcripts, a human immunodeficiency virus type 1 transcriptional element that activates the synthesis of short RNAs.\nMol Cell Biol\n1993;\n13:\n1251\u20131263.\n [PMC free article] [PubMed] [Google Scholar]122. \nPendergrast PS,\nHernandez N.\nRNA\u2010targeted activators, but not DNA\u2010targeted activators, repress the synthesis of short transcripts at the human immunodeficiency virus type 1 long terminal repeat.\nJ Virol\n1997;\n71:\n910\u2013917.\n [PMC free article] [PubMed] [Google Scholar]123. \nMorrison DJ,\nPendergrast PS,\nStavropoulos P,\nColmenares SU,\nKobayashi R,\nHernandez N.\nFBI\u20101, a factor that binds to the HIV\u20101 inducer of short transcripts (IST), is a POZ domain protein.\nNucleic Acids Res\n1999;\n27:\n1251\u20131262.\n [PMC free article] [PubMed] [Google Scholar]124. \nPendergrast PS,\nWang C,\nHernandez N,\nHuang S.\nFBI\u20101 can stimulate HIV\u20101 Tat activity and is targeted to a novel subnuclear domain that includes the Tat\u2010P\u2010TEFb\u2010containing nuclear speckles.\nMol Biol Cell\n2002, \n13:\n915\u2013929.\n [PMC free article] [PubMed] [Google Scholar]125. \nSelby MJ,\nBain ES,\nLuciw PA,\nPeterlin BM.\nStructure, sequence, and position of the stem\u2010loop in tar determine transcriptional elongation by tat through the HIV\u20101 long terminal repeat.\nGenes Dev\n1989; \n3:\n547\u2013558.\n [PubMed] [Google Scholar]126. \nDingwall C,\nErnberg I,\nGait MJ,\nGreen SM,\nHeaphy S,\nKarn J,\nLowe AD,\nSingh M,\nSkinner MA.\nHIV\u20101 tat protein stimulates transcription by binding to a U\u2010rich bulge in the stem of the TAR RNA structure.\nEMBO J\n1990;\n9:\n4145\u20134153.\n [PMC free article] [PubMed] [Google Scholar]127. \nWeeks, Crothers\n.\nRNA recognition by Tat\u2010derived peptides: Interaction in the major groove?\nCell\n1991; \n66:\n577\u2013588.\n [PubMed] [Google Scholar]128. \nChurcher MJ,\nLamont C,\nHamy F,\nDingwall C,\nGreen SM,\nLowe AD,\nButler JG,\nGait JM,\nKarn J.\nHigh affinity binding of TAR RNA by the human immunodeficiency virus type\u20101 tat protein requires base\u2010pairs in the RNA stem and amino acid residues flanking the basic region.\nJ Mol Biol\n1993;\n230:\n90\u2013110.\n [PubMed] [Google Scholar]129. \nPuglisi JD,\nTan R,\nCalnan BJ,\nFrankel AD,\nWilliamson JR.\nConformation of the TAR RNA\u2010arginine complex by NMR spectroscopy.\nScience\n1992;\n257:\n76\u201380.\n [PubMed] [Google Scholar]130. \nAboul\u2010ela F,\nKarn J,\nVarani G.\nThe structure of the human immunodeficiency virus type\u20101 TAR RNA reveals principles of RNA recognition by Tat protein.\nJ Mol Biol\n1995;\n253:\n313\u2013332.\n [PubMed] [Google Scholar]131. \nAboul\u2010ela F,\nKarn J,\nVarani G.\nStructure of HIV\u20101 TAR RNA in the absence of ligands reveals a novel conformation of the trinucleotide bulge.\nNucleic Acids Res\n1996;\n24:\n3974\u20133981.\n [PMC free article] [PubMed] [Google Scholar]132. \nPritchard CE,\nGrasby JA,\nHamy F,\nZacharek AM,\nSingh M,\nKarn J,\nGait MJ.\nMethylphosphonate mapping of phosphate contacts critical for RNA recognition by the human immunodeficiency virus tat and rev proteins.\nNucleic Acids Res\n1994;\n22:\n2592\u20132600.\n [PMC free article] [PubMed] [Google Scholar]133. \nHamy F,\nFelder ER,\nHeizmann G,\nLazdins J,\nAboul\u2010ela F,\nVarani G,\nKarn J,\nKlimkait T.\nAn inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV\u20101 replication.\nProc Natl Acad Sci USA\n1997; \n94:\n3548\u20133553.\n [PMC free article] [PubMed] [Google Scholar]134. \nHwang S,\nTamilarasu N,\nKibler K,\nCao H,\nAli A,\nPing YH,\nJeang KT,\nRana TM.\nDiscovery of a small molecule Tat\u2010trans\u2010activation\u2010responsive RNA antagonist that potently inhibits human immunodeficiency virus\u20101 replication.\nJ Biol Chem\n2003;\n278:\n39092\u201339103.\n [PubMed] [Google Scholar]135. \nChoudbury I,\nWang J,\nRabson AB,\nStein S,\nPooyan S,\nStein S,\nLeibowitz MJ.\nInhibition of HIV\u20101 replication by a Tat RNA\u2010binding domain peptide analog.\nJ Acquir Immune Defic Syndr Hum Retrovirol\n1998;\n17:\n104\u2013111.\n [PubMed] [Google Scholar]136. \nBaba M,\nOkamoto M,\nKawamura M,\nMakino M,\nHigashida T,\nTakashi T,\nKimura Y,\nIkeuchi T,\nTetsuka T,\nOkamoto T.\nInhibition of human immunodeficiency virus type 1 replication and cytokine production by fluoroquinoline derivatives.\nMol Pharmacol\n1998;\n53:\n1097\u20131103.\n [PubMed] [Google Scholar]137. \nRichter S,\nParolin C,\nGatto B,\nDel Vecchio C,\nBrocca\u2010Cofano E,\nFravolini A,\nPal\u00f9 G,\nPalumbo M.\nInhibition of human immunodeficiency virus type 1 tat\u2010trans\u2010activation\u2010responsive region interaction by an antiviral quinolone derivative.\nAntimicrob Agents Chemother\n2004;\n48:\n1895\u20131899.\n [PMC free article] [PubMed] [Google Scholar]138. \nMayhood T,\nKaushik N,\nPandey PK,\nKashanchi F,\nDeng L,\nPandey VN.\nInhibition of Tat\u2010mediated transactivation of HIV\u20101 LTR transcription by polyamide nucleic acid targeted to TAR hairpin element.\nBiochemistry\n2000;\n39:\n11532\u201311539.\n [PubMed] [Google Scholar]139. \nLitovchick A,\nEvdokimov AG,\nLapidot A.\nArginine\u2010aminoglycoside conjugates that bind to HIV transactivation responsive element RNA in vitro.\nFEBS Lett\n1999;\n445:\n73\u201379.\n [PubMed] [Google Scholar]140. \nMurchie AI,\nDavis B,\nIsel C,\nAfshar M,\nDrysdale MJ,\nBower J,\nPotter AJ,\nStarkey ID,\nSwarbrick TM,\nMirza S,\nPrescott CD,\nVaglio P,\nAboul\u2010ela F,\nKarn J.\nStructure\u2010based drug design targeting an inactive RNA conformation: Exploiting the flexibility of HIV\u20101 TAR RNA.\nJ Mol Biol\n2004;\n336:\n625\u2013638.\n [PubMed] [Google Scholar]141. \nDarfeuille F,\nArzumanov A,\nGait MJ,\nDi Primo C,\nToulme JJ.\n2\u2032\u2010O\u2010methyl\u2010RNA hairpins generate loop\u2010loop complexes and selectively inhibit HIV\u20101 Tat\u2010mediated transcription.\nBiochemistry\n2002;\n41:\n12186\u201312192.\n [PubMed] [Google Scholar]142. \nKolb G,\nReigadas S,\nBoiziau C,\nvan Aerschot A,\nArzumanov A,\nGait MJ,\nHerdewijn P,\nToulme JJ.\nHexitol nucleic acid\u2010containing aptamers are efficient ligands of HIV\u20101 TAR RNA.\nBiochemistry\n2005;\n44:\n2926\u20132933.\n [PubMed] [Google Scholar]143. \nSullenger BA,\nGallardo HF,\nUngers GE,\nGilboa E.\nAnalysis of trans\u2010acting response decoy RNA\u2010mediated inhibition of human immunodeficiency virus type 1 transactivation.\nJ Virol\n1991;\n65:\n6811\u20136816.\n [PMC free article] [PubMed] [Google Scholar]144. \nBohjanen PR,\nColvin RA,\nPuttaraju M,\nBeen MD,\nGarcia\u2010Blanco MA.\nA small circular TAR RNA decoy specifically inhibits Tat\u2010activated HIV\u20101 transcription.\nNucleic Acids Res\n1996;\n24:\n3733\u20133738.\n [PMC free article] [PubMed] [Google Scholar]145. \nMichienzi A,\nLi S,\nZaia JA,\nRossi JJ.\nA nucleolar TAR decoy inhibitor of HIV\u20101 replication.\nProc Natl Acad Sci USA\n2002;\n99:\n14047\u201314052.\n [PMC free article] [PubMed] [Google Scholar]146. \nSurabhi RM,\nGaynor RB.\nRNA interference directed against viral and cellular targets inhibits human immunodeficiency Virus Type 1 replication.\nJ Virol\n2002;\n76:\n12963\u201312973.\n [PMC free article] [PubMed] [Google Scholar]147. \nHoque M,\nYoung TM,\nLee CG,\nSerrero G,\nMathews MB,\nPe'ery T.\nThe growth factor granulin interacts with cyclin T1 and modulates P\u2010TEFb\u2010dependent transcription.\nMol Cell Biol\n2003;\n23:\n1688\u20131702.\n [PMC free article] [PubMed] [Google Scholar]148. \nHoque M,\nTian B,\nMathews MB,\nPe'ery T.\nGranulin and granulin repeats interact with the Tat.P\u2010TEFb complex and inhibit Tat transactivation.\nJ Biol Chem\n2005;\n280:\n13648\u201313657.\n [PubMed] [Google Scholar]149. \nMhashilkar AM,\nBagley J,\nChen SY,\nSzilvay AM,\nHelland DG,\nMarasco WA.\nInhibition of HIV\u20101 Tat\u2010mediated LTR transactivation and HIV\u20101 infection by anti\u2010Tat single chain intrabodies.\nEMBO J\n1995;\n14:\n1542\u20131551.\n [PMC free article] [PubMed] [Google Scholar]150. \nRe MC,\nFurlini G,\nVignoli M,\nRamazzotti E,\nRoderigo G,\nDe Rosa V,\nZauli G,\nLolli S,\nCapitani S,\nLa Placa M.\nEffect of antibody to HIV\u20101 Tat protein on viral replication in vitro and progression of HIV\u20101 disease in vivo.\nJ Acquir Immune Defic Syndr Hum Retrovirol\n1995;\n10:\n408\u2013416.\n [PubMed] [Google Scholar]151. \nCruikshank WW,\nDoctrow SR,\nFalvo MS,\nHuffman K,\nMaciaszek J,\nViglianti G,\nRaina J,\nKornfeld H,\nMalfroy B.\nA lipidated anti\u2010Tat antibody enters living cells and blocks HIV\u20101 viral replication.\nJ Acquir Immune Defic Syndr Hum Retrovirol\n1997;\n14:\n193\u2013203.\n [PubMed] [Google Scholar]152. \nBai J,\nSui J,\nZhu RY,\nTallarico AS,\nGennari F,\nZhang D,\nMarasco WA.\nInhibition of tat\u2010mediated transactivation and HIV\u20101 replication by human anti\u2010hCyclinT1 intrabodies.\nJ Biol Chem\n2002;\n278:\n1433\u20131442.\n [PubMed] [Google Scholar]153. \nRana TM,\nJeang KT.\nBiochemical and functional interactions between HIV\u20101 Tat protein and TAR RNA.\nArch Biochem Biophys\n1999;\n365:\n175\u2013185.\n [PubMed] [Google Scholar]154. \nGarcia JA,\nHarrich D,\nPearson L,\nMitsuyasu R,\nGaynor RB.\nFunctional domains required for tat\u2010induced transcriptional activation of the HIV\u20101 long terminal repeat.\nEMBO J\n1988;\n7:\n3143\u20133147.\n [PMC free article] [PubMed] [Google Scholar]155. \nRuben S,\nPerkins A,\nPurcell R,\nJoung K,\nSia R,\nBurghoff R,\nHaseltine WA,\nRosen CA.\nStructural and functional characterization of human immunodeficiency virus tat protein.\nJ Virol\n1989;\n63:\n1\u20138.\n [PMC free article] [PubMed] [Google Scholar]156. \nHauber J,\nMalim MH,\nCullen BR.\nMutational analysis of the conserved basic domain of human immunodeficiency virus tat protein.\nJ Virol\n1989;\n63:\n1181\u20131187.\n [PMC free article] [PubMed] [Google Scholar]157. \nVives E,\nBrodin P,\nLebleu B.\nA truncated HIV\u20101 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus.\nJ Biol Chem\n1997;\n272:\n16010\u201316017.\n [PubMed] [Google Scholar]158. \nFittipaldi A,\nGiacca M.\nTranscellular protein transduction using the Tat protein of HIV\u20101.\nAdv Drug Deliv Rev\n2005;\n57:\n597\u2013608.\n [PubMed] [Google Scholar]159. \nBuonaguro L,\nBarillari G,\nChang HK,\nBohan CA,\nKao V,\nMorgan R,\nGallo RC,\nEnsoli B.\nEffects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines.\nJ Virol\n1992;\n66:\n7159\u20137167.\n [PMC free article] [PubMed] [Google Scholar]160. \nPuri RK,\nAggarwal BB.\nHuman immunodeficiency virus type 1 tat gene up\u2010regulates interleukin 4 receptors on a human B\u2010lymphoblastoid cell line.\nCancer Res\n1992;\n52:\n3787\u20133790.\n [PubMed] [Google Scholar]161. \nEnsoli B,\nBuonaguro L,\nBarillari G,\nFiorelli V,\nGendelman R,\nMorgan RA,\nWingfield P,\nGallo RC.\nRelease, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation.\nJ Virol\n1993;\n67:\n277\u2013287.\n [PMC free article] [PubMed] [Google Scholar]162. \nLafrenie RM,\nWahl LM,\nEpstein JS,\nYamada KM,\nDhawan S.\nActivation of monocytes by HIV\u2010Tat treatment is mediated by cytokine expression.\nJ Immunol\n1997;\n159:\n4077\u20134083.\n [PubMed] [Google Scholar]163. \nAlbini A,\nBarillari G,\nBenelli R,\nGallo RC,\nEnsoli B.\nAngiogenic properties of human immunodeficiency virus type 1 Tat protein.\nProc Natl Acad Sci USA\n1995;\n92:\n4838\u20134842.\n [PMC free article] [PubMed] [Google Scholar]164. \nHerrmann CH,\nRice AP.\nSpecific interaction of the human immunodeficiency virus Tat proteins with a cellular protein kinase.\nVirology\n1993;\n197:\n601\u2013608.\n [PubMed] [Google Scholar]165. \nHerrmann CH,\nRice AP.\nLentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl\u2010terminal domain of the large subunit of RNA polymerase II: Candidate for a Tat cofactor.\nJ Virol\n1995;\n69:\n1612\u20131620.\n [PMC free article] [PubMed] [Google Scholar]166. \nZhu Y,\nPe'ery T,\nPeng J,\nRamanathan Y,\nMarshall N,\nMarshall T,\nAmendt B,\nMathews MB,\nPrice DH.\nTranscription elongation factor P\u2010TEFb is required for HIV\u20101 tat transactivation in vitro.\nGenes Dev\n1997;\n11:\n2622\u20132632.\n [PMC free article] [PubMed] [Google Scholar]167. \nIsel C,\nKarn J.\nDirect evidence that HIV\u20101 Tat stimulates RNA polymerase II carboxyl\u2010terminal domain hyperphosphorylation during transcriptional elongation.\nJ Mol Biol\n1999;\n290:\n929\u2013941.\n [PubMed] [Google Scholar]168. \nKim YK,\nBourgeois CF,\nIsel C,\nChurcher MJ,\nKarn J.\nPhosphorylation of the RNA polymerase II carboxyl\u2010terminal domain by CDK9 is directly responsible for human immunodeficiency virus type 1 Tat\u2010activated transcriptional elongation.\nMol Cell Biol\n2002;\n22:\n4622\u20134637.\n [PMC free article] [PubMed] [Google Scholar]169. \nZhou M,\nHalanski MA,\nRadonovich MF,\nKashanchi F,\nPeng J,\nPrice DH,\nBrady JN.\nTat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl\u2010terminal domain during human immunodeficiency virus type 1 transcription.\nMol Cell Biol\n2000;\n20:\n5077\u20135086.\n [PMC free article] [PubMed] [Google Scholar]170. \nPing YH,\nRana TM.\nTat\u2010associated kinase (P\u2010TEFb): A component of transcription preinitiation and elongation complexes.\nJ Biol Chem\n1999;\n274:\n7399\u20137404.\n [PubMed] [Google Scholar]171. \nZhou M,\nNekhai S,\nBharucha DC,\nKumar A,\nGe H,\nPrice DH,\nEgly JM,\nBrady JN.\nTFIIH inhibits CDK9 phosphorylation during human immunodeficiency virus type 1 transcription.\nJ Biol Chem\n2001;\n276:\n44633\u201344640.\n [PubMed] [Google Scholar]172. \nPing YH,\nRana TM.\nDSIF and NELF interact with RNA polymerase II elongation complex and HIV\u20101 Tat stimulates P\u2010TEFb\u2010mediated phosphorylation of RNA polymerase II and DSIF during transcription elongation.\nJ Biol Chem\n2001;\n276:\n12951\u201312958.\n [PubMed] [Google Scholar]173. \nKim JB,\nSharp PA.\nPositive transcription elongation factor B phosphorylates hSPT5 and RNA polymerase II carboxyl\u2010terminal domain independently of cyclin\u2010dependent kinase\u2010activating kinase.\nJ Biol Chem\n2001;\n276:\n12317\u201312323.\n [PubMed] [Google Scholar]174. \nBourgeois CF,\nKim YK,\nChurcher MJ,\nWest MJ,\nKarn J.\nSpt5 cooperates with human immunodeficiency virus type 1 Tat by preventing premature RNA release at terminator sequences.\nMol Cell Biol\n2002;\n22:\n1079\u20131093.\n [PMC free article] [PubMed] [Google Scholar]175. \nYamaguchi Y,\nInukai N,\nNarita T,\nWada T,\nHanda H.\nEvidence that negative elongation factor represses transcription elongation through binding to a DRB sensitivity\u2010inducing factor/RNA polymerase II complex and RNA.\nMol Cell Biol\n2002;\n22:\n2918\u20132927.\n [PMC free article] [PubMed] [Google Scholar]176. \nFujinaga K,\nIrwin D,\nHuang Y,\nTaube R,\nKurosu T,\nPeterlin BM.\nDynamics of human immunodeficiency virus transcription: P\u2010TEFb phosphorylates RD and dissociates negative effectors from the transactivation response element.\nMol Cell Biol\n2004;\n24:\n787\u2013795.\n [PMC free article] [PubMed] [Google Scholar]177. \nWei P,\nGarber ME,\nFang SM,\nFischer WH,\nJones KA.\nA novel CDK9\u2010associated C\u2010type cyclin interacts directly with HIV\u20101 Tat and mediates its high\u2010affinity, loop\u2010specific binding to TAR RNA.\nCell\n1998; \n92:\n451\u2013462.\n [PubMed] [Google Scholar]178. \nGarber ME,\nWei P,\nKewal Ramani VN,\nMayall TP,\nHerrmann CH,\nRice AP,\nLittman DR,\nJones KA.\nThe interaction between HIV\u20101 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein.\nGenes Dev\n1998;\n12:\n3512\u20133527.\n [PMC free article] [PubMed] [Google Scholar]179. \nBieniasz PD,\nGrdina TA,\nBogerd HP,\nCullen BR.\nRecruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV\u20101 Tat.\nEMBO J\n1998;\n17:\n7056\u20137065.\n [PMC free article] [PubMed] [Google Scholar]180. \nYang Z,\nZhu Q,\nLuo K,\nZhou Q.\nThe 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription.\nNature\n2001;\n414:\n317\u2013322.\n [PubMed] [Google Scholar]181. \nNguyen VT,\nKiss T,\nMichels AA,\nBensaude O.\n7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes.\nNature\n2001;\n414:\n322\u2013325.\n [PubMed] [Google Scholar]182. \nMichels AA,\nNguyen VT,\nFraldi A,\nLabas V,\nEdwards M,\nBonnet F,\nLania L,\nBensaude O.\nMAQ1 and 7SK RNA interact with CDK9/cyclin T complexes in a transcription\u2010dependent manner.\nMol Cell Biol\n2003; \n23:\n4859\u20134869.\n [PMC free article] [PubMed] [Google Scholar]183. \nMichels AA,\nFraldi A,\nLi Q,\nAdamson TE,\nBonnet F,\nNguyen VT,\nSedore SC,\nPrice JP,\nPrice DH,\nLania L,\nBensaude O.\nBinding of the 7SK snRNA turns the HEXIM1 protein into a P\u2010TEFb (CDK9/cyclin T) inhibitor.\nEMBO J\n2004;\n23:\n2608\u20132619.\n [PMC free article] [PubMed] [Google Scholar]184. \nYik JH,\nChen R,\nNishimura R,\nJennings JL,\nLink AJ,\nZhou Q.\nInhibition of P\u2010TEFb (CDK9/Cyclin T) kinase and RNA polymerase II transcription by the coordinated actions of HEXIM1 and 7SK snRNA.\nMol Cell\n2003;\n12:\n971\u2013982.\n [PubMed] [Google Scholar]185. \nYik JH,\nChen R,\nPezda AC,\nSamford CS,\nZhou Q.\nA human immunodeficiency virus type 1 Tat\u2010like arginine\u2010rich RNA\u2010binding domain is essential for HEXIM1 to inhibit RNA polymerase II transcription through 7SK snRNA\u2010mediated inactivation of P\u2010TEFb.\nMol Cell Biol\n2004;\n24:\n5094\u20135105.\n [PMC free article] [PubMed] [Google Scholar]186. \nSchulte A,\nCzudnochowski N,\nBarboric M,\nSchonichen A,\nBlazek D,\nPeterlin BM,\nGeyer M.\nIdentification of a cyclin T\u2010binding domain in Hexim1 and biochemical analysis of its binding competition with HIV\u20101 Tat.\nJ Biol Chem\n2005;\n280:\n24968\u201324977.\n [PubMed] [Google Scholar]187. \nChao SH,\nFujinaga K,\nMarion JE,\nTaube R,\nSausville EA,\nSenderowicz AM,\nPeterlin BM,\nPrice DH.\nFlavopiridol inhibits P\u2010TEFb and blocks HIV\u20101 replication.\nJ Biol Chem\n2000;\n275:\n28345\u201328348.\n [PubMed] [Google Scholar]188. \nWang D,\nde la Fuente C,\nDeng L,\nWang L,\nZilberman I,\nEadie C,\nHealey M,\nStein D,\nDenny T,\nHarrison LE,\nMeijer L,\nKashanchi F.\nInhibition of human immunodeficiency virus type 1 transcription by chemical cyclin\u2010dependent kinase inhibitors.\nJ Virol\n2001;\n75:\n7266\u20137279.\n [PMC free article] [PubMed] [Google Scholar]189. \nAgbottah E,\nde la Fuente C,\nNekhai S,\nBarnett A,\nGianella\u2010Borradori A,\nKashanchi F.\nAntiviral activity of CYC202 in HIV\u20101\u2010infected cells.\nJ Biol Chem\n2005;\n280:\n3029\u20133042.\n [PubMed] [Google Scholar]190. \nNekhai S,\nZhou M,\nFernandez A,\nLane WS,\nLamb NJ,\nBrady J,\nKumar A.\nHIV\u20101 Tat\u2010associated RNA polymerase C\u2010terminal domain kinase, CDK2, phosphorylates CDK7 and stimulates Tat\u2010mediated transcription.\nBiochem J\n2002;\n364:\n649\u2013657.\n [PMC free article] [PubMed] [Google Scholar]191. \nDeng L,\nAmmosova T,\nPumfery A,\nKashanchi F,\nNekhai S.\nHIV\u20101 Tat interaction with RNA polymerase II C\u2010terminal domain (CTD) and a dynamic association with CDK2 induce CTD phosphorylation and transcription from HIV\u20101 promoter.\nJ Biol Chem\n2002;\n277:\n33922\u201333929.\n [PubMed] [Google Scholar]192. \nGarber ME,\nMayall TP,\nSuess EM,\nMeisenhelder J,\nThompson NE,\nJones KA.\nCDK9 autophosphorylation regulates high\u2010affinity binding of the human immunodeficiency virus type 1 tat\u2010P\u2010TEFb complex to TAR RNA.\nMol Cell Biol\n2000;\n20:\n6958\u20136969.\n [PMC free article] [PubMed] [Google Scholar]193. \nFong YW,\nZhou Q.\nRelief of two built\u2010in autoinhibitory mechanisms in P\u2010TEFb is required for assembly of a multicomponent transcription elongation complex at the human immunodeficiency virus type 1 promoter.\nMol Cell Biol\n2000;\n20:\n5897\u20135907.\n [PMC free article] [PubMed] [Google Scholar]194. \nZhou Q,\nSharp PA.\nTat\u2010SF1: Cofactor for stimulation of transcriptional elongation by HIV\u20101 Tat.\nScience\n1996;\n274:\n605\u2013610.\n [PubMed] [Google Scholar]195. \nFong YW,\nZhou Q.\nStimulatory effect of splicing factors on transcriptional elongation.\nNature\n2001;\n414:\n929\u2013933.\n [PubMed] [Google Scholar]196. \nSune C,\nHayashi T,\nLiu Y,\nLane WS,\nYoung RA,\nGarcia\u2010Blanco MA.\nCA150, a nuclear protein associated with the RNA polymerase II holoenzyme, is involved in Tat\u2010activated human immunodeficiency virus type 1 transcription.\nMol Cell Biol\n1997;\n17:\n6029\u20136039.\n [PMC free article] [PubMed] [Google Scholar]197. \nGoldstrohm AC,\nAlbrecht TR,\nSune C,\nBedford MT,\nGarcia\u2010Blanco MA.\nThe transcription elongation factor CA150 interacts with RNA polymerase II and the pre\u2010mRNA splicing factor SF1.\nMol Cell Biol\n2001;\n21:\n7617\u20137628.\n [PMC free article] [PubMed] [Google Scholar]198. \nSmith MJ,\nKulkarni S,\nPawson T.\nFF domains of CA150 bind transcription and splicing factors through multiple weak interactions.\nMol Cell Biol\n2004;\n24:\n9274\u20139285.\n [PMC free article] [PubMed] [Google Scholar]199. \nBr\u00e8s V,\nGomes N,\nPickle L,\nJones KA.\nA human splicing factor, SKIP, associates with P\u2010TEFb and enhances transcription elongation by HIV\u20101 Tat.\nGenes Dev\n2005;\n19:\n1211\u20131226.\n [PMC free article] [PubMed] [Google Scholar]200. \nChiu YL,\nCoronel E,\nHo CK,\nShuman S,\nRana TM.\nHIV\u20101 Tat protein interacts with mammalian capping enzyme and stimulates capping of TAR RNA.\nJ Biol Chem\n2001;\n276:\n12959\u201312966.\n [PubMed] [Google Scholar]201. \nChiu YL,\nHo CK,\nSaha N,\nSchwer B,\nShuman S,\nRana TM.\nTat stimulates cotranscriptional capping of HIV mRNA.\nMol Cell\n2002;\n10:\n585\u2013597.\n [PubMed] [Google Scholar]202. \nZhou M,\nDeng L,\nKashanchi F,\nBrady JN,\nShatkin AJ,\nKumar A.\nThe Tat/TAR\u2010dependent phosphorylation of RNA polymerase II C\u2010terminal domain stimulates cotranscriptional capping of HIV\u20101 mRNA.\nProc Natl Acad Sci USA\n2003;\n100:\n12666\u201312671.\n [PMC free article] [PubMed] [Google Scholar]203. \nMarshall NF,\nDahmus GK,\nDahmus ME.\nRegulation of carboxyl\u2010terminal domain phosphatase by HIV\u20101 tat protein.\nJ Biol Chem\n1998;\n273:\n31726\u201331730.\n [PubMed] [Google Scholar]204. \nMarshall NF,\nDahmus ME.\nC\u2010terminal domain phosphatase sensitivity of RNA polymerase II in early elongation complexes on the HIV\u20101 and adenovirus 2 major late templates.\nJ Biol Chem\n2000;\n275:\n32430\u201332437.\n [PubMed] [Google Scholar]205. \nAbbott KL,\nArchambault J,\nXiao H,\nNguyen BD,\nRoeder RG,\nGreenblatt J,\nOmichinski JG,\nLegault P.\nInteractions of the HIV\u20101 Tat and RAP74 proteins with the RNA polymerase II CTD phosphatase FCP1.\nBiochemistry\n2005;\n44:\n2716\u20132731.\n [PubMed] [Google Scholar]206. \nWashington K,\nAmmosova T,\nBeullens M,\nJerebtsova M,\nKumar A,\nBollen M,\nNekhai S.\nProtein phosphatase\u20101 dephosphorylates the C\u2010terminal domain of RNA polymerase\u2010II.\nJ Biol Chem\n2002;\n277:\n40442\u201340448.\n [PubMed] [Google Scholar]207. \nAmmosova T,\nJerebtsova M,\nBeullens M,\nVoloshin Y,\nRay PE,\nKumar A,\nBollen M,\nNekhai S.\nNuclear protein phosphatase\u20101 regulates HIV\u20101 transcription.\nJ Biol Chem\n2003;\n278:\n32189\u201332194.\n [PubMed] [Google Scholar]208. \nKamine J,\nElangovan B,\nSubramanian T,\nColeman D,\nChinnadurai G.\nIdentification of a cellular protein that specifically interacts with the essential cysteine region of the HIV\u20101 Tat transactivator.\nVirology\n1996;\n216:\n357\u2013366.\n [PubMed] [Google Scholar]209. \nYamamoto T,\nHorikoshi M.\nNovel substrate specificity of the histone acetyltransferase activity of HIV\u20101\u2010Tat interactive protein Tip60.\nJ Biol Chem\n1997;\n272:\n30595\u201330598.\n [PubMed] [Google Scholar]210. \nLiu Y,\nLi J,\nKim BO,\nPace BS,\nHe JJ.\nHIV\u20101 Tat protein\u2010mediated transactivation of the HIV\u20101 long terminal repeat promoter is potentiated by a novel nuclear Tat\u2010interacting protein of 110 kDa, Tip110.\nJ Biol Chem\n2002;\n277:\n23854\u201323863.\n [PubMed] [Google Scholar]211. \nWeissman JD,\nBrown JA,\nHowcroft TK,\nHwang J,\nChawla A,\nRoche PA,\nSchiltz L,\nNakatani Y,\nSinger DS.\nHIV\u20101 tat binds TAFII250 and represses TAFII250\u2010dependent transcription of major histocompatibility class I genes.\nProc Natl Acad Sci USA\n1998;\n95:\n11601\u201311606.\n [PMC free article] [PubMed] [Google Scholar]212. \nCol E,\nCaron C,\nSeigneurin\u2010Berny D,\nGracia J,\nFavier A,\nKhochbin S.\nThe histone acetyltransferase, hGCN5, interacts with and acetylates the HIV transactivator.\nTat J Biol Chem\n2001;\n276:\n28179\u201328184.\n [PubMed] [Google Scholar]213. \nBenkirane M,\nChun RF,\nXiao H,\nOgryzko VV,\nHoward BH,\nNakatani Y,\nJeang KT.\nActivation of integrated provirus requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV\u20101 Tat.\nJ Biol Chem\n1998;\n273:\n24898\u201324905.\n [PubMed] [Google Scholar]214. \nMarzio G,\nTyagi M,\nGutierrez MI,\nGiacca M.\nHIV\u20101 tat transactivator recruits p300 and CREB\u2010binding protein histone acetyltransferases to the viral promoter.\nProc Natl Acad Sci USA\n1998;\n95:\n13519\u201313524.\n [PMC free article] [PubMed] [Google Scholar]215. \nHottiger MO,\nNabel GJ.\nInteraction of human immunodeficiency virus type 1 Tat with the transcriptional coactivators p300 and CREB binding protein.\nJ Virol\n1998;\n72:\n8252\u20138256.\n [PMC free article] [PubMed] [Google Scholar]216. \nKiernan RE,\nVanhulle C,\nSchiltz L,\nAdam E,\nXiao H,\nMaudoux F,\nCalomme C,\nBurny A,\nNakatani Y,\nJeang KT,\nBenkirane M,\nVan Lint C.\nAcetylation of the HIV\u20101 Tat protein by p300 is important for its transcriptional activity.\nEMBO J\n1999;\n18:\n6106\u20136118.\n [PMC free article] [PubMed] [Google Scholar]217. \nBr\u00e8s V,\nTagami H,\nP\u00e9lopon\u00e8se JM,\nLoret E,\nJeang KT,\nNakatani Y,\nEmiliani S,\nBenkirane M,\nKiernan RE.\nDifferential acetylation of Tat coordinates its interaction with the co\u2010activators cyclin T1 and PCAF.\nEMBO J\n2002;\n21:\n6811\u20136819.\n [PMC free article] [PubMed] [Google Scholar]218. \nOtt M,\nSchnolzer M,\nGarnica J,\nFischle W,\nEmiliani S,\nRackwitz HR,\nVerdin E.\nHIV\u20101 tat transcriptional activity is regulated by acetylation.\nCurr Biol\n1999;\n9:\n1489\u20131492.\n [PubMed] [Google Scholar]219. \nKaehlcke K,\nDorr A,\nHetzer\u2010Egger C,\nKiermer V,\nHenklein P,\nSchnoelzer M,\nLoret E,\nCole PA,\nVerdin E,\nOtt M.\nAcetylation of Tat defines a cyclinT1\u2010independent step in HIV transactivation.\nMol Cell\n2003;\n12:\n167\u2013176.\n [PubMed] [Google Scholar]220. \nCujec TP,\nCho H,\nMaldonado E,\nMeyer J,\nReinberg D,\nPeterlin BM.\nThe human immunodeficiency virus transactivator Tat interacts with the RNA polymerase II holoenzyme.\nMol Cell Biol\n1997;\n17:\n1817\u20131823.\n [PMC free article] [PubMed] [Google Scholar]221. \nZhou C,\nRana TM.\nA bimolecular mechanism of HIV\u20101 Tat protein interaction with RNA polymerase II transcription elongation complexes.\nJ Mol Biol\n2002;\n320:\n925\u2013942.\n [PubMed] [Google Scholar]222. \nMujtaba S,\nHe Y,\nZeng L,\nFarooq A,\nCarlson JE,\nOtt M,\nVerdin E,\nZhou MM.\nStructural basis of lysine\u2010acetylated HIV\u20101 Tat recognition by PCAF bromodomain.\nMol Cell\n2002;\n9:\n575\u2013586.\n [PubMed] [Google Scholar]223. \nDorr A,\nKiermer V,\nPedal A,\nRackwitz HR,\nHenklein P,\nSchubert U,\nZhou MM,\nVerdin E,\nOtt M.\nTranscriptional synergy between Tat and PCAF is dependent on the binding of acetylated Tat to the PCAF bromodomain.\nEMBO J\n2002;\n21:\n2715\u20132723.\n [PMC free article] [PubMed] [Google Scholar]224. \nBarthelemy S,\nVergnes L,\nMoynier M,\nGuyot D,\nLabidalle S,\nBahraoui E.\nCurcumin and curcumin derivatives inhibit Tat\u2010mediated transactivation of type 1 human immunodeficiency virus long terminal repeat.\nRes Virol\n1998;\n149:\n43\u201352.\n [PubMed] [Google Scholar]225. \nBalasubramanyam K,\nVarier RA,\nAltaf M,\nSwaminathan V,\nSiddappa NB,\nRanga U,\nKundu TK.\nCurcumin, a novel p300/CREB\u2010binding protein\u2010specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase\u2010dependent chromatin transcription.\nJ Biol Chem\n2004;\n279:\n51163\u201351171.\n [PubMed] [Google Scholar]226. \nPagans S,\nAngelika P,\nNorth BJ,\nKaehlcke K,\nMarshall BL,\nDorr A,\nHetzer\u2010Egger C,\nHenklein P,\nFrye R,\nMcBurney MW,\nHruby H,\nJung M,\nVerdin E,\nOtt M.\nSIRT1 regulates HIV transcription via Tat deacetylation.\nPLoS Biol\n2005;\n3:\n210\u2013220.\n [PMC free article] [PubMed] [Google Scholar]227. \nBr\u00e8s V,\nKiernan RE,\nLinares LK,\nChable\u2010Bessia C,\nPlechakova O,\nTr\u00e9and C,\nEmiliani S,\nPeloponese JM,\nJeang KT,\nCoux O,\nScheffner M,\nBenkirane M.\nA non\u2010proteolytic role for ubiquitin in Tat\u2010mediated transactivation of the HIV\u20101 promoter.\nNat Cell Biol\n2003;\n5:\n754\u2013761.\n [PubMed] [Google Scholar]228. \nBoulanger MC,\nLiang C,\nRussell RS,\nLin R,\nBedford MT,\nWainberg MA,\nRichard S.\nMethylation of Tat by PRMT6 regulates human immunodeficiency virus type 1 gene expression.\nJ Virol\n2005;\n79:\n124\u2013131.\n [PMC free article] [PubMed] [Google Scholar]"}